Journal
MOLECULES
Volume 25, Issue 7, Pages -Publisher
MDPI
DOI: 10.3390/molecules25071591
Keywords
Brassica; clinical trials; glucosinolates
Funding
- Fundacion Seneca, Murcia Regional Agency for Science and Technology [20855/PI/18]
Ask authors/readers for more resources
Brassica vegetables and their components, the glucosinolates, have been suggested as good candidates as dietary coadjutants to improve health in non-communicable diseases (NCDs). Different preclinical and clinical studies have been performed in the last decade; however, some concerns have been posed on the lack of established and standardized protocols. The different concentration of bioactive compounds used, time of intervention or sample size, and the lack of blinding are some factors that may influence the studies' outcomes. This review aims to analyze the critical points of the studies performed with Brassica-related biomolecules and propose some bases for future trials in order to avoid biases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available